Risk Factors for Endometrial Cancer
The major risk factors for endometrial cancer are obesity (with BMI >30 conferring a 273% increased risk), prolonged unopposed estrogen exposure, nulliparity, and Lynch syndrome, with obesity being the single most important modifiable risk factor driving the increasing incidence and mortality of this disease 1.
Anthropometric and Metabolic Factors
Obesity stands as the most significant modifiable risk factor, with a dose-dependent relationship clearly established 1, 2:
- BMI 22-27.2: +21% increased risk
- BMI 27.5-29.5: +43% increased risk
- BMI >30: +273% increased risk
Body mass index per 5 kg/m² increase confers a relative risk of 1.49 (95% CI 1.39-1.61) in premenopausal women, representing strong evidence without hints of bias 2. Waist-to-hip ratio also demonstrates strong evidence, with each 0.1 unit increase associated with RR 1.21 (95% CI 1.13-1.29) 2.
Related metabolic conditions include:
Hormonal and Reproductive Factors
Unopposed estrogen exposure represents a critical hormonal risk factor through multiple mechanisms 1, 3, 4:
Endogenous sources:
- Nulliparity (conversely, parity reduces risk with RR 0.66,95% CI 0.60-0.74, representing strong evidence) 2
- Polycystic ovarian syndrome with chronic anovulation 1, 3
- Infertility 1
- Younger age at menarche 4
- Late menopause 4
Exogenous sources:
- Tamoxifen use for breast cancer treatment 1, 5, 4
- Unopposed estrogen hormone replacement therapy 5, 3
- Estrogen-producing tumors 4
Genetic Factors
Lynch syndrome (hereditary non-polyposis colorectal cancer syndrome) confers a 10-fold increased risk of endometrial cancer 1. Women with Lynch syndrome develop microsatellite-unstable tumors at younger ages and face elevated risks of colon and ovarian cancers 1. Ovarian preservation should not be performed in patients with germline mutations in MLH1, MSH2, MSH6, or PMS2 6.
Additional genetic considerations:
- BRCA mutation carriers require careful counseling regarding ovarian preservation 6
- Family history of gynecologic cancers warrants heightened surveillance 3
- 5-10% of endometrial cancers are hereditary, though >90% are sporadic 1
Age and Geographic Distribution
The majority of cases occur between 65-75 years of age 1. Endometrial cancer is more prevalent in high/intermediate developed countries, with increasing age representing a non-modifiable risk factor 3.
Clinical Implications
The rising mortality rates (1.9% per year on average) are primarily attributed to the obesity epidemic 1, making weight management and metabolic syndrome control critical prevention strategies. The fact that 80% of endometrial cancers are confined to the uterus at diagnosis due to early postmenopausal bleeding 1 underscores the importance of prompt evaluation of any abnormal uterine bleeding, particularly in women with multiple risk factors.
Common pitfall: Failing to recognize Lynch syndrome in younger patients with endometrial cancer, which requires specific genetic testing and cascade screening of family members for appropriate cancer surveillance.